Chromium, zinc and magnesium status in type 1 diabetes

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 18, Issue 6, 2015, Pages 588-592

  Lin, Ching Chiang ^a,b   Huang, Yeou Lih ^a,c,d,e  

^a FOOYIN UNIVERSITY   (Taiwan)

^b FOOYIN UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Chromium; Magnesium; Type 1 diabetes mellitus; Zinc

Indexed keywords

CHROMIUM; MAGNESIUM; ZINC; GLUCOSE BLOOD LEVEL; TRACE ELEMENT;

CHROMIUM BLOOD LEVEL; CORRELATION ANALYSIS; DISEASE CONTROL; GLYCEMIC CONTROL; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MAGNESIUM BLOOD LEVEL; MINERAL SUPPLEMENTATION; NONHUMAN; OXIDATIVE STRESS; REVIEW; ZINC BLOOD LEVEL; ANIMAL; BLOOD; COMPLICATION; DEFICIENCY; DIABETES MELLITUS; DIETARY SUPPLEMENT; GLUCOSE BLOOD LEVEL; MAGNESIUM DEFICIENCY; METABOLISM; NUTRITIONAL STATUS;

ANIMALS; BLOOD GLUCOSE; CHROMIUM; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIETARY SUPPLEMENTS; HUMANS; MAGNESIUM; MAGNESIUM DEFICIENCY; NUTRITIONAL STATUS; OXIDATIVE STRESS; TRACE ELEMENTS; ZINC;

EID: 84944076886     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000225     Document Type: Review

References (27)

1. van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 2011; 91:79-118.
2. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific opinion on dietary reference values for chromium. J EFSA 2014; 12:3845-3870.
3. Lin CC, Huang HH, Hu CW, et al. Trace elements, oxidative stress and glycemic control in young people with type 1 diabetes mellitus. J Trace Elem Med Biol 2014; 28:18-22.
4. Peruzzu A, Solinas G, Asara Y, et al. Association of trace elements with lipid profiles and glycaemic control in patients with type 1 diabetes mellitus in northern Sardinia, Italy: an observational study. Chemosphere 2015; 132:101-107.
5. Valera P, Zavattari P, Albanese S, et al. A correlation study between multiple sclerosis and type 1 diabetes incidences and geochemical data in Europe. Environ Geochem Health 2014; 36:79-98.
6. Junnila SK. Type 1 diabetes epidemic in Finland is triggered by zinc-containing amorphous silica nanoparticles. Med Hypotheses 2015; 84:336-340.
7. Kaur B, Henry J. Micronutrient status in type 2 diabetes: a review. Adv Food Nutr Res 2014; 71:55-100.
8. Lewicki S, Zdanowski R, Krzyzowska M, et al. The role of Chromium III in the organism and its possible use in diabetes and obesity treatment. Ann Agric Environ Med 2014; 21:331-335.
9. Lin CC, Tsweng GJ, Lee CF, et al. Magnesium, zinc, and chromium levels in children, adolescents, and young adults with type 1 diabetes. Clin Nutr 2015. [Epub ahead of print]. doi: http://dx.doi.org/10.1016/j.clnu.2015.05.022.
10. Ozenc S, Saldir M, Sari E, et al. Selenium, zinc, and copper levels and their relation with HbA1c status in children with type 1 diabetes mellitus. Int J Diabetes Dev Ctries 2015. [Epub ahead of print]. doi: 10.1007/s13410-015-0327-y.
11. Basu A, Yu JY, Jenkins AJ, et al. Trace elements as predictors of preeclampsia in type 1 diabetic pregnancy. Nutr Res 2015; 35:421-430.
12. de Baaij JHF, Hoenderop JGJ, Bindels RJM. Magnesium in man: implications for health and disease. Physiol Rev 2015; 95:1-46.
13. Dibaba DT, Xun P, Fly AD, et al. Dietary magnesium intake and risk of metabolic syndrome: a meta-Analysis. Diabet Med 2014; 31:1301-1309.
14. Galli-Tsinopoulou A, Maggana I, Kyrgios I, et al. Association between magnesium concentration and HbA1c in children and adolescents with type 1 diabetes mellitus. J Diabetes 2014; 6:369-377.
15. Bicer M, Akil M, Baltaci AK, et al. Effect of melatonin on element distribution in the liver tissue of diabetic rats subjected to forced exercise. Bratisl Lek Listy 2015; 116:119-123.
16. Stefanowicz F, Gashut RA, Talwar D, et al. Assessment of plasma and red cell trace element concentrations, disease severity, and outcome in patients with critical illness. J Crit Care 2014; 29:214-218.
17. De Paula RCS, Aneni EC, Costa APR, et al. Low zinc levels is associated with increased inflammatory activity but not with atherosclerosis, arteriosclerosis or endothelial dysfunction among the very elderly. BBA Clin 2014; 2:1-6.
18. Nielsen FH. Effects of magnesium depletion on inflammation in chronic disease. Curr Opin Clin Nutr Metab Care 2014; 17:525-530.
19. Dibaba DT, Xun P, He K. Dietary magnesium intake is inversely associated with serum C-reactive protein levels: meta-Analysis and systematic review. Eur J Clin Nutr 2014; 68:510-516.
20. Salmonowicz B, Krzystek-Korpacka M, Noczynska A. Trace elements, magnesium, and the efficacy of antioxidant systems in children with type 1 diabetes mellitus and in their siblings. Adv Clin Exp Med 2014; 23:259-268.
21. Tang HY, Xiao QG, Xu HB, Zhang Y. Hypoglycemic activity and acute oral toxicity of chromium methionine complexes in mice. J Trace Elem Med Biol 2015; 29:136-144.
22. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific opinion on dietary reference values for zinc. J EFSA 2014; 12:3844-3920.
23. Cruz KJ, de Oliveira AR, Marreiro Ddo N. Antioxidant role of zinc in diabetes mellitus. World J Diabetes 2015; 6:333-337.
24. Jayawardena R, Ranasinghe P, Galappatthy P, et al. Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-Analysis. Diabetol Metab Syndr 2012; 4:13.
25. Liang TT, Zhang Q, Sun WX, et al. Zinc treatment prevents type 1 diabetesinduced hepatic oxidative damage, endoplasmic reticulum stress, and cell death, and even prevents possible steatohepatitis in the OVE26 mouse model: important role of metallothionein. Toxicol Lett 2015; 233:114-124.
26. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2015. Draft scientific opinion on dietary reference values for magnesium. J EFSA 2015; 13:4186-4249.
27. Hruby A, Meigs JB, ODonnell CJ, et al. Higher magnesium intake reduces risk of impaired glucose and insulin metabolism and progression from prediabetes to diabetes in middle-Aged americans. Diabetes Care 2014; 37:419-427.